SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001571049-17-007998
Filing Date
2017-09-22
Accepted
2017-09-22 08:30:29
Documents
5
Period of Report
2017-11-06
Effectiveness Date
2017-09-22

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT t1702290-def14a.htm DEF 14A 483164
2 GRAPHIC lg_phibrocorp-cmyk.jpg GRAPHIC 70242
3 GRAPHIC sg_thomas-dagger.jpg GRAPHIC 13593
4 GRAPHIC t1702290_pc1.jpg GRAPHIC 292544
5 GRAPHIC t1702290_pc2.jpg GRAPHIC 199891
  Complete submission text file 0001571049-17-007998.txt   1259891
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-36410 | Film No.: 171096735
SIC: 2834 Pharmaceutical Preparations